IONS — Ionis Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedLarge CapNeutral

Annual balance sheet for Ionis Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	C2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-Q	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	1,892	2,115	1,987	2,331	2,298
Net Total Accounts Receivable
Net Total Receivables	76.2	61.9	25.5	97.8	92.2
Total Inventory
Total Other Current Assets
Total Current Assets	2,131	2,345	2,203	2,642	2,620
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	181	196	256	243	256
Net Intangible Assets
Other Long Term Assets
Total Assets	2,390	2,612	2,534	2,990	3,004
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	599	241	312	448	309
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	1,646	1,840	1,961	2,603	2,415
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	743	772	573	387	588
Total Liabilities & Shareholders' Equity	2,390	2,612	2,534	2,990	3,004
Total Common Shares Outstanding